DK3466982T3 - Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation - Google Patents

Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation Download PDF

Info

Publication number
DK3466982T3
DK3466982T3 DK18199835.2T DK18199835T DK3466982T3 DK 3466982 T3 DK3466982 T3 DK 3466982T3 DK 18199835 T DK18199835 T DK 18199835T DK 3466982 T3 DK3466982 T3 DK 3466982T3
Authority
DK
Denmark
Prior art keywords
polysaccharid
manipulation
separation
streptococcus pneumoniae
polluting
Prior art date
Application number
DK18199835.2T
Other languages
English (en)
Inventor
Brian Bahler
Tsu-Shun Lee
Jason Arnold Lotvin
Mark Edward Ruppen
Pamela Sue Fink Charbonneau
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36660782&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3466982(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Application granted granted Critical
Publication of DK3466982T3 publication Critical patent/DK3466982T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/085Staphylococcus
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
DK18199835.2T 2005-04-08 2006-03-31 Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation DK3466982T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66954605P 2005-04-08 2005-04-08
EP06740302.2A EP1866342B1 (en) 2005-04-08 2006-03-31 Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation

Publications (1)

Publication Number Publication Date
DK3466982T3 true DK3466982T3 (da) 2020-08-03

Family

ID=36660782

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18199835.2T DK3466982T3 (da) 2005-04-08 2006-03-31 Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation
DK06740302.2T DK1866342T3 (da) 2005-04-08 2006-03-31 Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06740302.2T DK1866342T3 (da) 2005-04-08 2006-03-31 Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation

Country Status (20)

Country Link
US (1) US7718791B2 (da)
EP (2) EP1866342B1 (da)
JP (1) JP5049264B2 (da)
KR (1) KR101317256B1 (da)
CN (1) CN101155833B (da)
AR (1) AR053843A1 (da)
AU (1) AU2006234984B2 (da)
BR (1) BRPI0607026B1 (da)
CA (1) CA2604362C (da)
DK (2) DK3466982T3 (da)
ES (2) ES2808126T3 (da)
HU (1) HUE050049T2 (da)
IL (1) IL186366A (da)
MX (1) MX2007012337A (da)
NZ (1) NZ562719A (da)
PL (2) PL1866342T3 (da)
PT (2) PT1866342T (da)
SI (2) SI3466982T1 (da)
TR (1) TR201820018T4 (da)
WO (1) WO2006110352A2 (da)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007307800C1 (en) * 2006-10-10 2014-03-13 Wyeth Llc Purification of Streptococcus pneumoniae type 3 polysaccharides
AU2013201631C1 (en) * 2006-10-10 2015-06-04 Wyeth Llc Purification of Streptococcus pneumoniae type 3 polysaccharides
DK2129693T3 (da) * 2007-03-23 2017-02-13 Wyeth Llc Afkortet oprensningsfremgangsmåde til fremstilling af streptococcus pneumoniae-kapselpolysaccharider
GB0822634D0 (en) 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
DK2379734T3 (da) * 2008-12-18 2018-04-23 Wyeth Llc Fremgangsmåde til at styre molekylvægten af polysaccharid af streptococcus pneumoniae serotype 19A
CN102257127B (zh) 2008-12-18 2014-01-01 惠氏有限责任公司 使用二氧化碳控制肺炎链球菌多糖分子量的方法
CN104548082A (zh) 2009-03-24 2015-04-29 诺华股份有限公司 为脑膜炎球菌因子h结合蛋白添加佐剂
BRPI1009829A2 (pt) 2009-03-24 2016-11-16 Novartis Ag combinações de proteína de ligação de fator h meningocócico e conjugados de sacarídeos pneumocócicos
EP2424562B1 (en) 2009-04-30 2015-10-07 Coley Pharmaceutical Group, Inc. Pneumococcal vaccine and uses thereof
WO2011145108A2 (en) * 2010-05-15 2011-11-24 Serum Institute Of India Ltd. Purification of capsular polysaccharides
CA2803239A1 (en) 2010-06-25 2011-12-29 Novartis Ag Combinations of meningococcal factor h binding proteins
CN102094053B (zh) * 2010-11-26 2013-01-16 兰州生物制品研究所有限责任公司 肺炎链球菌c多糖的纯化方法
CN102093963B (zh) * 2010-11-26 2012-11-14 兰州生物制品研究所有限责任公司 富含磷壁酸的肺炎链球菌的培养方法
RU2013144207A (ru) 2011-03-02 2015-04-10 Новартис Аг Комбинированные вакцины с пониженными дозами антигена и/или адъюванта
AU2011384634A1 (en) 2011-12-29 2014-06-19 Novartis Ag Adjuvanted combinations of meningococcal factor H binding proteins
WO2013131983A1 (en) 2012-03-07 2013-09-12 Novartis Ag Adjuvanted formulations of streptococcus pneumoniae antigens
EP2822584A1 (en) 2012-03-08 2015-01-14 Novartis AG Combination vaccines with tlr4 agonists
CN102660603B (zh) * 2012-04-17 2015-03-25 江苏康泰生物医学技术有限公司 一种快速纯化细菌荚膜多糖的方法
CN102660602B (zh) * 2012-04-17 2015-03-25 江苏康泰生物医学技术有限公司 快速纯化细菌荚膜多糖的方法
CN102660601B (zh) * 2012-04-17 2015-10-28 江苏康泰生物医学技术有限公司 快速纯化细菌荚膜多糖的方法
CA2882619A1 (en) 2012-09-06 2014-03-13 Novartis Ag Combination vaccines with serogroup b meningococcus and d/t/p
EP2894225B1 (en) * 2012-09-07 2017-11-22 SK Chemicals Co., Ltd. Production method for capsular polysaccharide having pneumococcal serotype
CN105007935A (zh) 2012-12-18 2015-10-28 葛兰素史密丝克莱恩生物有限公司 用于保护免于白喉和/或破伤风的缀合物
MX371454B (es) 2014-01-21 2020-01-29 Pfizer Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
PE20212335A1 (es) 2014-01-21 2021-12-16 Pfizer Composiciones inmunogenicas que comprenden antigenos sacaridos capsulares conjugados y usos de los mismos
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
RU2743793C1 (ru) 2014-01-21 2021-02-26 Пфайзер Инк. Капсульные полисахариды Streptococcus pneumoniae и их конъюгаты
PT3244917T (pt) 2015-01-15 2023-05-31 Pfizer Composições imunogénicas para utilização em vacinas pneumocócicas
MY182282A (en) 2015-05-04 2021-01-18 Pfizer Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
KR102225282B1 (ko) 2015-07-21 2021-03-10 화이자 인코포레이티드 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
EP3377098A1 (en) 2015-11-20 2018-09-26 Pfizer Inc Immunogenic compositions for use in pneumococcal vaccines
CN109862908B (zh) 2016-08-05 2023-05-02 圣诺菲·帕斯图尔公司 多价肺炎球菌多糖-蛋白质缀合物组合物
MX2019001341A (es) 2016-08-05 2019-07-04 Sanofi Pasteur Inc Composicion de conjugado de polisacarido neumococico multivalente-proteina.
US10751402B2 (en) 2016-11-09 2020-08-25 Pfizer Inc. Immunogenic compositions and uses thereof
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
BR112019013475A2 (pt) 2016-12-30 2020-02-27 Sutrovax, Inc. Conjugados de polipeptídeo-antígeno com aminoácidos não naturais
WO2018134693A1 (en) 2017-01-20 2018-07-26 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
EP3576784A4 (en) 2017-01-31 2020-11-11 Merck Sharp & Dohme Corp. PROCESS FOR THE PRODUCTION OF POLYSACCHARIDE PROTEIN CONJUGATES
CN107043431B (zh) * 2017-02-23 2020-06-30 上海瑞宙生物科技有限公司 细菌性荚膜多糖的纯化方法
WO2018156491A1 (en) 2017-02-24 2018-08-30 Merck Sharp & Dohme Corp. Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates
EP3678653A4 (en) 2017-09-07 2021-05-26 Merck Sharp & Dohme Corp. ANTIPNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN POLYSACCHARIDE-CARRIER PROTEIN IMMUNOGENIC CONJUGATES
KR20200051005A (ko) 2017-09-07 2020-05-12 머크 샤프 앤드 돔 코포레이션 폐렴구균 폴리사카라이드 및 면역원성 폴리사카라이드-담체 단백질 접합체에서의 그의 용도
CA3084436A1 (en) 2017-12-06 2019-07-18 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
JP7397000B2 (ja) 2018-04-30 2023-12-12 メルク・シャープ・アンド・ドーム・エルエルシー 凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
WO2020010000A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Improved methods for the preparation of immunogenic conjugates
KR20210042904A (ko) 2018-07-04 2021-04-20 박사이트, 인코포레이티드 면역원성 접합체의 개선
CA3120922A1 (en) 2018-12-12 2020-06-18 Pfizer Inc. Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
AU2019401535B2 (en) 2018-12-19 2023-12-14 Merck Sharp & Dohme Llc Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
JP7239509B6 (ja) * 2019-02-22 2023-03-28 ファイザー・インク 細菌多糖類を精製するための方法
WO2020208502A1 (en) 2019-04-10 2020-10-15 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
WO2021021729A1 (en) 2019-07-31 2021-02-04 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
US20210070890A1 (en) * 2019-09-06 2021-03-11 Serum Institute Of India Private Limited Method for obtaining purified bacterial polysaccharides
US20230321212A1 (en) 2020-08-26 2023-10-12 Pfizer Inc. Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
GB202016165D0 (en) 2020-10-12 2020-11-25 Optivalent Ltd Vaccine
WO2022097010A1 (en) 2020-11-04 2022-05-12 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
WO2022101745A2 (en) 2020-11-10 2022-05-19 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
EP4333879A1 (en) 2021-05-03 2024-03-13 Pfizer Inc. Vaccination against bacterial and betacoronavirus infections
WO2022234416A1 (en) 2021-05-03 2022-11-10 Pfizer Inc. Vaccination against pneumoccocal and covid-19 infections
US20220387576A1 (en) 2021-05-28 2022-12-08 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
PE20240090A1 (es) 2021-05-28 2024-01-16 Pfizer Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos
WO2023135515A1 (en) 2022-01-13 2023-07-20 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
GB2614916A (en) 2022-01-25 2023-07-26 Optivalent Ltd Intradermal vaccine complement
WO2023161817A1 (en) 2022-02-25 2023-08-31 Pfizer Inc. Methods for incorporating azido groups in bacterial capsular polysaccharides
CN114853917A (zh) * 2022-04-22 2022-08-05 兰州生物制品研究所有限责任公司 制备肺炎球菌荚膜多糖和肺炎球菌疫苗的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1115210A (en) * 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
US4242501A (en) * 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
FR2495939B1 (fr) * 1980-12-11 1985-10-11 Merieux Inst Procede de purification de polyosides de streptococcus pneumoniae et vaccin a base de polyosides ainsi purifies
BE889979A (fr) 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
US5714354A (en) * 1995-06-06 1998-02-03 American Home Products Corporation Alcohol-free pneumococcal polysaccharide purification process
WO2000006738A2 (en) * 1998-07-27 2000-02-10 Microbial Technics Limited NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
AU2001245795B2 (en) * 2000-03-16 2005-07-28 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide

Also Published As

Publication number Publication date
PT3466982T (pt) 2020-07-24
KR101317256B1 (ko) 2013-10-14
AR053843A1 (es) 2007-05-23
PT1866342T (pt) 2019-01-30
SI3466982T1 (sl) 2020-08-31
AU2006234984B2 (en) 2011-10-13
CN101155833B (zh) 2011-04-20
EP3466982B1 (en) 2020-06-17
MX2007012337A (es) 2007-11-21
CA2604362A1 (en) 2006-10-19
NZ562719A (en) 2008-12-24
JP5049264B2 (ja) 2012-10-17
US7718791B2 (en) 2010-05-18
CN101155833A (zh) 2008-04-02
SI1866342T1 (sl) 2019-02-28
US20060228381A1 (en) 2006-10-12
PL3466982T3 (pl) 2020-11-02
TR201820018T4 (tr) 2019-01-21
WO2006110352A3 (en) 2007-03-29
AU2006234984A1 (en) 2006-10-19
EP3466982A1 (en) 2019-04-10
IL186366A0 (en) 2008-01-20
ES2808126T3 (es) 2021-02-25
BRPI0607026B1 (pt) 2022-02-15
CA2604362C (en) 2013-11-12
WO2006110352A2 (en) 2006-10-19
EP1866342B1 (en) 2018-11-21
EP1866342A2 (en) 2007-12-19
DK1866342T3 (da) 2019-01-28
HUE050049T2 (hu) 2020-11-30
ES2707202T3 (es) 2019-04-02
IL186366A (en) 2012-10-31
KR20080005414A (ko) 2008-01-11
PL1866342T3 (pl) 2019-04-30
JP2008535490A (ja) 2008-09-04
BRPI0607026A2 (pt) 2009-07-28

Similar Documents

Publication Publication Date Title
DK3466982T3 (da) Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation
DE112006001685A5 (de) Trennverfahren
ATE475473T1 (de) Trennverfahren
DE112006004277A5 (de) Glaszusammensetzung
ZA200808372B (en) Antibody purification
IL185380A0 (en) ANTI-MAdCAM ANTIBODY COMPOSITIONS
DK3330339T3 (da) Sammensætninger omfattende hfc-1234ze
DE602006000212D1 (de) Industrielles Fahrzeug
DE602006013906D1 (de) Ausgleichsgetriebe für Kraftfahrzeug
DE602006005328D1 (de) Differentialgehäuse
NO20054623L (no) Filterelement for drikkeboks
DK2107865T3 (da) Køretøj til udbringning af gylle
DE602006017145D1 (de) Fahrzeuge
DE502006000127D1 (de) Abscheidevorrichtung
DK1867900T3 (da) Adskillelseselement
DE602005021170D1 (de) Positionssuchverfahren
BRPI0718218A2 (pt) Recuperação de petróleo
DE602006015274D1 (de) Mikroskopsystem
DK1957720T3 (da) Separator til fjernelse af urenheder, især mindre partikler, fra regnvand
DE602006001141D1 (de) Azimuth-ausgerichtete NMR-Proben
DE502006003341D1 (de) Kondensationsverfahren
DK1787516T3 (da) Kiminhiberende sammensætning
ITUD20050078A1 (it) Gruppo disidratore compatto
ITBS20050095A1 (it) Interruttore differenziale
ITBO20050041A1 (it) Gruppo di segnalazione stradale